
A meta-analysis of CREDENCE, DECLARE-TIMI 58, CANVAS, and EMPA-REG OUTCOME trial is revealing more about how SGLT2 inhibition impacts different subgroups of diabetics.

A meta-analysis of CREDENCE, DECLARE-TIMI 58, CANVAS, and EMPA-REG OUTCOME trial is revealing more about how SGLT2 inhibition impacts different subgroups of diabetics.

New weekly report data shows the count of jurisdictions with high influenza-like illness activity has risen again.

Discussing which potential AMD treatments retina specialists are most excited about moving forward.

Anita Clayton, MD, the David C. Wilson Professor and Chair of the Department of Psychiatry and Neurobehavioral Sciences at the University of Virginia, reports on some of the exciting new treatments in the pipeline for depression.

Discussing the most effective ways new therapies can reduce the treatment burden of current age-related macular degeneration treatments.

Anita Clayton, the David C. Wilson Professor and Chair of the Department of Psychiatry and Neurobehavioral Sciences at the University of Virginia, explains how doctors can talk to patients about some of the side effects from antipsychotic medications.

The oral treatment becomes the first of its kind indicated for the reduction of food allergic reaction risks and severity in the US.

New research into the role of legislation on vaping use shows certain laws may be more effective than others.

A family physician takes lead on a discussion around the changing makeup of care teams.

A telehealth program is not significantly better than usual care for patients presenting to the emergency department with a behavioral health crisis.

A new analysis of more than 15,000 Europeans found bariatric surgery could reduce all-cause mortality and heart failure.

Mindfulness therapy, along with usual care for depression, results in a reduction in residual depressive symptoms.

A vegetarian diet was linked to a 16% decrease in developing a urinary tract infection, according to an analysis of more than 9000 Taiwanese patients.

Investigators will move forward with a phase 2 study testing AV-101 as a potential treatment for patients with Parkinson disease receiving levodopa-based therapy.

Investigators report a positive incremental net monetary benefit of nearly $6800 when patients with heart failure use a telehealth solution.

New cohort data shows significantly worsened respiratory symptoms among patients with comorbid cough and COPD.

An analysis of the Southern Community Cohort Study found differences in the impact of modifiable risk factors for heart failure among black and white patients.

In a placebo-controlled study, CBD attenuated hippocampal-striatal functional connectivity and caused trend-level symptom reduction in psychosis patients.

Data from an analysis of the Rush Memory and Aging Project found consumption of flavonols was tied to a decreased risk of developing Alzheimer dementia.

A survey of more than 1500 doctors from the United Kingdom found 31% reported being burnt out and stressed.

Higher ACR levels following an acute kidney injury is linked to an increased risk of kidney disease progression.

Pharmacosmos Therapeutics Inc. announced the FDA granted approval of ferric derisomaltose injection for the treatment of iron deficiency anemia.

In a clinical trial, roluperidone reduces the level of centrality associated with avolition for schizophrenia patients.

Digital cognitive behavioral therapy for pregnant women is a safe and effective alternative to medications for the condition.

In an industry-wide survey, 72.2% of healthcare providers report satisfaction with their own success.

The findings of a recent study emphasize the importance of learning the risk factors that contribute to pediatric suicide.

PDUFA target action date set for November 15, 2020 for the new combination olanzapine/samidorphan treatment.

The remote patient monitoring platform delivers data directly to the physician and reduces hospitalizations and emergency department trips.

The FDA will rule on the type 2 inflammation-targeting biologic for another indication this May.

The SoMeDocs founder shares thoughts on doctors developing an online brand, the burden of being an uncredited expert on social media, and the benefit of committing to the platforms.